Replies to post #6109 on ANI Pharmaceuticals (ANIP)

[Yodle]

Thanks JTFM.

Agreed 100% - "Libigel" (or whatever it ends up being called) is just one part of the equation. So impressed by the ambitious (yet surprisingly realistic) vision of ANIP leadership.

Under promise, over deliver. They're really making the magic happen.

I try not to get too pumped about any one company, but barring any unforeseen circumstances, the future is looking very bright, indeed. Even on up days like today, I still think ANIP is flying under the radar at this point.

[Yodle]

ANIP Highlighted in the Motley Fool.

JTFM is spot on...

"ANI Pharmaceuticals also has an impressive generic drug pipeline. As of the end of the third quarter, ANI had 78 products in development with a total annual market size of $3.7 billion based on data from IMS Health."

The Greatest Small-Cap Stocks You've Never Heard About